Skip to main content
. 2022 Jun 30;33(2):185–195. doi: 10.31138/mjr.33.2.185

Table 2.

Baseline demographic and clinical characteristics of 165 patients with AA amyloidosis associated with several inflammatory diseases.

Clinical and laboratory variables n (%) Mean ± SD Range

Age 165 45.4±12.7 21–78

Sex
  Male 85 (51.5)
  Female 80 (48.5)

Age of onset (FMF) 25.9±14.2

Family history of FMF 92 (59)

Duration of Amyloidosis (months) 130.9±99 1–504

Age of onset (Amyloidosis) 33.5±14 5–70

Etiology of Amyloidosis
  FMF 128 (77.6)
  AS 8 (4.8)
  Idiopathic 13 (7.9)
RA 2 (1.2)
TRAPS 2 (1.2)
Takayasu 2 (1.2)
DADA2 2 (1.2)
GPA 1 (0.6)
Crohn’s disease 1 (0.6)
AOSD 1 (0.6)
PsA 3 (1.8)
Gout 1 (0.6)
  Behçet’s disease 1 (0.6)

FMF: Familial Mediterranean fever; AS: Ankylosing spondylitis; RA: Rheumatoid arthritis; TRAPS: TNF receptor associated periodic syndrome; DADA2: Deficiency of adenosine deaminase 2; GPA: Granulomatosis with polyangiitis; AOSD: Adult onset still disease; PsA: Psoriatic arthritis; SD: Standard deviation.